Yukiko Gotoh

In an interview with Neuron, Yukiko Gotoh shares how limitations imposed by the pandemic have proven inspirational, including how neuroscience may inform the development of tools to improve virtual reality and online communication, and how technology and automation might help

Shubha Tole

Shubha Tole, Dean of Graduate Studies at the Tata Institute of Fundamental Research in Mumbai, India, shares with Neuron her approach to mentorship during these challenging times, how connecting diverse perspectives across the globe makes us stronger, and her love

Welcome all

Neuron traditionally publishes a themed collection of reviews to coincide with the Society for Neuroscience’s (SfN) annual meeting. When we were brainstorming potential topics in the spring of 2021, with COVID-19 vaccinations rolling out in many parts of the world

Autoimmune nodopathies: treatable neuropathies beyond traditional classifications

Precise characterisation of the target antigens and autoantibody isotypes improves patient care in inflammatory neuropathies Antibodies targeting all neurofascin isoforms (pan-neurofascin) have been associated with variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) that include ataxic presentations, cranial nerve involvement, respiratory

At the dawn of personalised medicine in neuromyelitis optica spectrum disorder: the impact of the disease activity on pregnancy

A retrospective cohort observation analysing risks of pregnancy-related attacks in neuromyelitis optica spectrum disorder patients Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system characterised by optic neuritis and myelitis, which commonly affects young women


Migraine is a ubiquitous neurologic disorder that is estimated to affect approximately 1 billion people worldwide, predominantly females. According to the Global Burden of Disease Study 2016, migraine is the second leading cause of disability and accounts for more disability

China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations

China faces the greatest challenge from stroke in the world. The death rate for cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million deaths in 2018. It ranked third among the leading causes of death behind

WhatsApp WhatsApp'tan Bize Yazın